STOCKS TELEGRAPH

Tag: Teladoc Health

  • Teladoc Health, Inc. (TDOC) stock surged in the Current Market; here is why?

    Teladoc Health, Inc. (TDOC) gained in the current market after announcing its partnership with Amazon Alexa. TDOC values at $77.05, gaining more than 9% compared to Friday’s closing price. The stock closed at $70.73 at the end of the last trading session. The stock volume traded in the last trading session was around 4.71 million shares. The current market cap of the company is around $12.17 billion.

    TDOC partners with Amazon Alexa

    Teladoc Health, Inc. (TDOC) announced in a press release today that they have entered into a joint venture with Amazon to launch Teladoc Health on Alexa. With this deal, Alexa users in the US will be able to connect with Teledoc care providers. The service will provide 24/7. This is a very new experience of the company with Amazon Alexa, due to which users will be able to reach virtual health care support via Teledoc on the supported Echo devices. These devices include Echo, Echo Dot, and Echo Show. In the first phase of the launch, they will provide audio support, and soon video support will also be launched.

    TDOC CPO Remarks

    Teladoc Health’s chief product officer Donna Boyer said the partnership with Amazon is another step toward lowering healthcare costs. We are giving a new and easy option for people to interact with a doctor by combining our virtual first care experience with Echo devices. We are reaching customers where they are to keep members happy.

    TDOC Recently Announced Fiscal 2021 Results

    Its revenue was around $2.3 billion in fiscal 2021, increasing more than 86%. The company is expanding its operation, which is why its profitability was negative. That is why the company reported a net loss of $428.8 million.

    For this reason, the corporation has published its financial projections in light of the pandemic uncertainty. Revenues of $565 million to $571 million are expected in the first quarter of 2022, according to TDOC. According to the company’s estimates, it will earn between $2.55 million and $2.65 billion in the next fiscal year. With a loss per share expected to range from $$0.60-$0.50 in Q1, they foresee a $$1.60-$1.40 loss per share for the whole fiscal year of 2022.

    Conclusion

    The current deal with Amazon Alexa will bring more customers to the company. It will also increase its brand positioning and get closer to its target audience.

  • Teladoc Health, Inc. (TDOC) stock declined in the after-hours; here is why?

    Teladoc Health, Inc. (TDOC) declined in the after-hours market after announcing its fourth quarter and fiscal 2021 results. TDOC values at $62.16, losing more than 4.8% compared to yesterday’s closing price. The stock closed at $65.30 at the end of the last trading session. The stock volume traded in the last trading session was around 4.21 million shares. The current market cap of the company is around $10.45 billion.

    TDOC: Key Financials

    • Teladoc Health, Inc. (TDOC) revenue in Q4 2021 was $554.2 million. It is a gain of more than 45% compared to the revenue of Q4 in 2020. The Q4 2020 revenue was $383.3 million.
    • Fiscal year revenue was $2.03 billion, and it is an increase of more than 86% compared to the revenue in fiscal 2020. The fiscal 2020 revenue was $1.09 billion.
    • The company’s net loss in Q4 2021 was around $11 million. The net loss was $394 million in Q4 2020.
    • TDOC net loss in fiscal 2021 was around $428.8 million, compared to the net loss of $485.1 million in fiscal 2020.
    • The Q4 2021 loss per share was $0.07.
    • For fiscal 2021, the loss per share was $2.73.

    TDOC CEO’s Remarks

    Teladoc Health CEO Jason Gorevic said that Teladoc Health made excellent progress in 2021 in providing complete whole-person care. We met our goals, earned our clients’ trust, and connected millions of people to exceptional treatment. We will always be the first choice for customers seeking healthcare.

    Teladoc Health’s extensive virtual care services link chronic, primary, acute, and specialist care patients. We saw substantial growth and penetration in various crucial areas of our firm using BetterHelp direct-to-consumer and MyStrength Complete B2B2C strategies for proper treatment at the perfect time.

    TDOC 2022 Outlook

    The company has provided its expected financial numbers in light of the uncertain situation of a pandemic. TDOC expects revenue between $565 million to $571 million in the first quarter of 2022. For fiscal 2022, the company expects revenue between $2.55 million to $2.65 billion. They expect a loss per share of $0.60 to $0.50 in Q1, and for fiscal 2022 it anticipates a loss per share of $$1.60 to $1.40.

    Conclusion

    The company’s revenue guidance shows a gain of around 25 to 30%. The company is focusing on increasing its market share and reaching more target audiences. That is why its revenue is increasing but is not profitable yet. They are focusing on the company’s growth, and profitability is the later part of such strategies.

  • Top 3 Health Care Stocks that can attract investors in 2021

    Top 3 Health Care Stocks that can attract investors in 2021

    Health care is a trillion-dollar industry because health is a global need. A trillion-dollar industry means plenty of companies making millions or billions of dollars annually in the health sector. With the surge of COVID-19, this industry has attracted plethora of investors to invest in healthcare stocks but many of them find it difficult to select the right stock at the right time. This is because many companies have claimed that they are working on vaccines and related products to cope with COVID-19 but only a few of them have found their way to commercialize their products. One should consider the fact that only COVID-19 is not the opportunity to invest in stocks but there are other health issues that demand a great amount of interest. So, investors need to do a large amount of homework before investing in any stock. Here are the few health care stocks that can attract investors in 2021.

    Eli Lilly And Co (NYSE:LLY)

    Eli Lilly and Company (LLY) is an American Pharmaceutical company that focuses on discovering, developing, manufacturing, and commercializing drugs for the cure of various kinds of diseases. The company is doing research and production in many nations and 120 countries are using its products.

    Eli Lilly Generated handsome revenue in 2020 through the sales of its top products which include Trulicity (Diabetes medicine), Basaglar (Insulin product), and Jardiance (Oral Diabetes drug). Trulicity generated $3.6 billion revenue in the first three quarters of 2020 with a rise of 22%. Similarly, Basaglar generated 842$ million revenue with a rise of 5% and Jardiance showed a rise of 24% with 840$ million income.

    The company has got positive results in phase 2 clinical trial of one of its potential drugs for Alzheimer’s disease called donanemab. More than 5 Million Alzheimer’s patients exist in the U.S and still, there is no approved drug for the cure. Still, donanemab has a long way to go for approval but investors can monitor its progress.

    The company reported on Tuesday that its late-stage coronavirus treatment trial which includesBamlanivimab (LY-CoV555) 2800 mg and Etesevimab (LY-CoV016), has reduced the riskof death in serious patients and hospitalization by 70% which is pointing out the bright future of the company and investors in terms of revenue.

    Hence Lilly has a good chance to outperform in the future due to its revenue growth, solid stock price performance, and good cash flow from operations.

    Teladoc Health Inc (NYSE:TDOC)

    Teladoc Health, Inc. (TDOC) is a virtual healthcare company playing a lead role in providing the services of diagnosis, treatment recommendation, and prescription through mobile phones and video consultations. The current pandemic situation is suitable for the company when people do not bother to go out of their homes unnecessarily. The company is getting fame day by day due to its best virtual health care services in remote areas and attracting institutional investors to invest in it.

    Though Teladoc has not revealed the 2020 report but rough estimates show that it has now more than 50 million members, facilitated more than 10 million visits, and generated about 1.1$ billion revenue in 2020 which is almost double than the previous year. Currently, many companies are providing Teladoc’s health care services to their employees which is expecting to grow in the future. Teladoc’s recent acquisition of Lovingo Health is also creating a more positive vibe for investors.

    CVS Health Corp (NYSE:CVS)

    CVS Health Corporation (CVS) is an integrated pharmacy healthcare service provider company. It offers pharmacy benefit management plans, health plans, prescription drug plans, and serves the government as well as private employees of many companies. It possesses nearly 10000 drug stores and1100 Minute Clinics in the U.S.The company is playing a key role in COVID-19 testing and is contributing a lot in the vaccination campaign as it has performed nearly 10 million coronavirus tests and 700,000 vaccinations. The company is currently handling 10% of coronavirus vaccination in the U.S and can vaccinate 25 million people per month.

    CVS is not just relying on COVID vaccination but also fighting against influenza by vaccinating people. The company generated $67 billion in the 3rd quarter of 2020 with a rise of 3.5% in its sales. Moreover, the company possesses more than 23 million health insurance members nationwide. Thanks to Aetna, a CVS subsidiary, which generates more than $18.5 billion per quarter in health insurance fees.

    The company is currently in a good position and has ample profit to sustain its dividend. Its shares are expecting to outperform in 2021 due to active participation in COVID-19 vaccination in the U.S.It can be a  good choice for dividend as well as growth investors.

  • Top Telehealth Stocks To Watch In January 2021

    Top Telehealth Stocks To Watch In January 2021

    Telehealth companies help people see medical professionals remotely through either the phone or video calls. And since the demand for healthcare with elements of social distancing increased during the pandemic, telemedicine services also saw an increase in demand. In the United States, when Congress passed an emergency fund of $8.3 billion, it also loosened certain rules on the use of telehealth services in the U.S. Medicare program. A lot of companies have branched into telehealth but only trade over the counter or are privately owned, except for Teladoc Health which trades on the New York Stock Exchange and has outperformed the broader market and has a market value of $12.2 billion.

    Teladoc Health Inc (NYSE: TDOC)

    Teladoc Health Inc (TDOC)‎ is one of the best telehealth stocks on Wall Street and benefited from the entire Covid pandemic ordeal since virtual healthcare became a big thing. The company gives virtual healthcare services to a wide range of stakeholders and its revenue more than doubled since then. Teladoc Health managed to close the third quarter last year with the $18.5 billion acquisition of its rival Livongo in October.

    In 2020, TDOC’s stocks began to look pricey because they had more than doubled up. It is a compelling growth story within the healthcare sector and is bound to bring in new investors over the years. It is already dubbed as a Strong Buy by 13 of the 27 analysts tracking for the S&P Global Market Intelligence.

    American Well Corp (NYSE: AMWL)

    American Well Corp (AMWL)‎ is a top-notch telemedicine company based in the United States and is rated 885 out of 1,000 which is higher than the 856 average in the industry. Amwell is part of 55 health plans at the moment and it used by nearly 36,000 employers. But the situation created by the pandemic proved to be extremely profitable for the company as seen in the visits to its platform since 2006 having been 5.6 million out of which 2.9 million of those visits happened till the middle of 2020.

    Its revenue increased by 77 per cent in the first half of 2020 by $122.3 million and its monthly visit volumes also saw a more than fourfold increase. In August, it also succeeded in securing a $100 million investment from Google, and much of that will go towards research and development and also in innovating the platform. AMWL is currently capitalized with $831.6 million in cash and investments and since September its stock is up by 70 per cent.

    M3

    M3 has been a global leader in telehealth in Japan and overseas. It is backed by Sony and initially began as a traditional operator of medical websites but it then used its acquisitions to become a provider of online medical information and telehealth. Much of M3’s revenue comes from the information it makes available to its academics, patients, and doctors. But that still makes it very profitable with a market capitalization of more than $60 billion. Its stock has been tripling over the past year as its capabilities have made it a strong stock and even the best emerging telehealth stock in the market.

    During the pandemic it gained 72 per cent for the year to date and it is predicted that with its outsized growth rate if it had been in the S&P 500, it would have been the top fifth index of the most expensive stocks.